Milan Baars

Milan Baars is a Researcher in the Department of Obstetrics & Gynecology at Erasmus MC, Rotterdam. His work focuses on maternal-fetal medicine with specialization in hypertensive disorders of pregnancy, particularly preeclampsia, where he investigates pharmacological interventions and biomarker dynamics to improve clinical outcomes.

His research centers on the pathophysiology of preeclampsia, emphasizing angiogenic factors (sFlt-1, PlGF), vasoactive substances (endothelin-1), and drug mechanisms like omeprazole. He employs rigorous clinical trial methodologies to evaluate therapeutic efficacy in high-risk pregnancies, bridging laboratory findings with patient care. Current work explores biomarker-guided treatment strategies for preterm preeclampsia, targeting molecular pathways to mitigate maternal and fetal complications.

Dr. Baars' 2022 publication in Hypertension demonstrates his focus on translational research, analyzing how omeprazole modulates key biomarkers in preterm preeclampsia. This work reflects broader trends in obstetric pharmacology toward repurposing existing drugs for pregnancy-specific conditions, with significant implications for managing angiogenic imbalances and vascular dysfunction in hypertensive pregnancy disorders.